Porton(SZ:300363) GUOTAI HAITONG SECURITIES·2025-11-10 13:02Investment Rating - The investment rating for the company is "Accumulate" [6][11]. Core Views - The traditional business is recovering growth, while emerging businesses are gradually ramping up, leading to improved profitability quarter by quarter [2]. - The company achieved a revenue of 2.544 billion yuan in Q1-Q3 2025, representing a year-on-year increase of 19.7%, and a net profit attributable to shareholders of 79.92 million yuan, marking a significant turnaround from losses [11]. - The target price is set at 31.26 yuan, reflecting an upward adjustment based on the company's emerging business capacity and asset utilization improvements [11]. Financial Summary - Total revenue is projected to be 3.667 billion yuan in 2023, decreasing to 3.012 billion yuan in 2024, before recovering to 3.495 billion yuan in 2025, with a growth rate of 16.0% [4]. - Net profit attributable to shareholders is expected to decline to -288 million yuan in 2024, before rebounding to 121 million yuan in 2025, with a significant year-on-year growth of 142.0% [4]. - Earnings per share (EPS) is forecasted to be 0.22 yuan in 2025, increasing to 0.88 yuan by 2027 [4]. Business Performance - Revenue from small molecule APIs reached 2.350 billion yuan in Q1-Q3 2025, up 19.4% year-on-year, while emerging business revenue was 190 million yuan, up 23.4% [11]. - The company reported a gross margin of 28.86% in Q1-Q3 2025, an increase of 5.6 percentage points year-on-year [11]. - The overseas market revenue was 1.805 billion yuan, reflecting a year-on-year increase of 17%, while the domestic market revenue was 739 million yuan, up 21% [11]. Valuation Metrics - The company is currently trading at a price-to-earnings (P/E) ratio of 50.34, with an expected P/E of 111.22 in 2025 [4]. - The price-to-book (P/B) ratio is 2.5 at the current price [7]. - The company has a net asset return rate (ROE) of 4.6% in 2023, projected to improve to 7.8% by 2027 [4].